65 Biggest Movers From Yesterday

Gainers

Society Pass Incorporated SOPA shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.
Bluerock Residential Growth REIT, Inc. BRG surged 76.2% to close at $27.20. Blackstone agreed to buy Bluerock Residential Growth REIT in a deal valued at $3.6 billion, extending its push into U.S. rental housing.
Can-Fite BioPharma Ltd. CANF rose 69.3% to settle at $2.15 after the company announced a liver cancer patient was cleared of all cancer lesions.
Verso Corporation VRS shares jumped 34.9% to close at $27.04 after the company announced it would be acquired by BillerundKorsnas for $27 per share.
AeroClean Technologies, Inc. AERC gained 33.7% to settle at $11.31.
AeroClean Technologies recently announced plans to install Pūrgo devices at MADabolic Jupiter.
Cue Health Inc. HLTH jumped 28.9% to settle at $12.63. Cue Health recently appointed Nitin Duggal as its first Chief Marketing Officer.
Galera Therapeutics, Inc. GRTX rose 28% to settle at $3.79. Citigroup maintained Galera Therapeutics with a Buy and raised the price target from $11 to $20.
BioDelivery Sciences International, Inc. BDSI gained 26.9% to close at $3.30. BioDelivery Sciences said the US District Court issued opinion in favor of the company in patent litigation against Alvogen.
Roivant Sciences Ltd. ROIV climbed 23.5% to settle at $13.52 after gaining 18% on Friday.
Lucira Health, Inc. LHDX gained 22.9% to close at $6.70.
HeartBeam, Inc. BEAT jumped 21.5% to settle at $3.56. Benchmark initiated coverage on BioTelemetry with a Speculative Buy rating and announced a price target of $9.
Lineage Cell Therapeutics, Inc. LCTX gained 21.2% to close at $2.57. Lineage Cell Therapeutics entered into an exclusive worldwide collaboration and license agreement with Roche Holdings’ Genentech to develop and commercialize retinal pigment epithelium (RPE) cell therapy.
Innovid Corp. CTV jumped 20.7% to settle at $8.15. Evercore ISI Group recently initiated coverage on Innovid with an Outperform rating and announced a price target of $10.
StarTek, Inc. SRT climbed 20.6% to settle at $4.75.
The Oncology Institute, Inc. TOI gained 19.6% to close at $7.63.
Quotient Limited QTNT rose 19.5% to close at $2.70. Quotient recently won a $77 million Defense Logistics Agency contract.
Local Bounti Corporation LOCL surged 19% to settle at $6.44.
Fortuna Silver Mines Inc. FSM gained 17.7% to close at $3.79 after the company announced the SEMARNAT granted a twelve year extension of the environmental impact authorization at the San Jose Mine, located in Oaxaca, Mexico.
Aridis Pharmaceuticals, Inc. ARDS surged 17.6% to settle at $2.54. Aridis Pharmaceuticals recently reported a Q3 loss of $1.94 per share.
New Pacific Metals Corp. NEWP gained 17.6% to close at $3.01.
Talaris Therapeutics, Inc. TALS jumped 17.3% to settle at $14.85 after the stock was added to the Nasdaq Biotechnology Index.
Energy Focus, Inc. EFOI gained 16.9% to close at $3.88.
Intra-Cellular Therapies, Inc. ITCI rose 15.8% to close at $45.35 after the company's Caplyta was approved by the FDA for bipolar depression.
Preferred Apartment Communities, Inc. APTS gained 15.2% to settle at $16.57.
Biomea Fusion, Inc. BMEA surged 14.4% to close at $8.26. Oppenheimer recently initiated coverage on Biomea Fusion with an Outperform rating and announced a price target of $22.
Lottery.com Inc. LTRY gained 14.1% to settle at $5.99.
Backblaze, Inc. BLZE surged 13.6% to close at $19.49.
Backblaze recently posted a Q3 loss of $0.32 per share.
BP Midstream Partners LP BPMP rose 13.3% to close at $14.63. BP announced agreement to acquire remaining stake in BP Midstream Partners, Reuters reported.
TeraWulf Inc. WULF jumped 13.1% to settle at $14.65.
Limelight Networks, Inc. LLNW jumped 12% to settle at $3.63. Raymond James upgraded Limelight Networks from Market Perform to Strong Buy.
Calliditas Therapeutics AB CALT gained 11.9% to close at $26.26 after HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $52 to $62. Calliditas Therapeutics recently announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
GBS Inc. GBS climbed 11.1% to settle at $1.40 after dipping 23% on Friday. GBS recently announced application for FDA breakthrough device designation to fast track rapid saliva glucose test.
CIT Group Inc. CIT gained 10% to close at $50.94. First Citizens recently announced receipt of regulatory approvals for deal with CIT.
argenx SE ARGX jumped 9% to settle at $337.51 after the company announced the FDA approved VYVGART for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive.
KemPharm, Inc. KMPH gained 6.8% to close at $8.31 as the company reported authorization of $50 million buyback.

Check out these big penny stock gainers and losers

Losers

Summit Therapeutics Inc. SMMT shares tumbled 48% to close at $2.59 on Monday after reporting topline results for Phase III Ri-CoDIFy study for C. Difficile infection. The company said Ri-CoDIFy did not meet primary endpoint.
Insignia Systems, Inc. ISIG dropped 35.1% to settle at $11.50.
Nutriband Inc. NTRB fell 23.6% to settle at $3.14.
Optical Cable Corporation OCC fell 21% to close at $5.09 after the company reported Q4 earnings results.
PARTS iD, Inc. ID fell 19.2% to settle at $2.15.
Immix Biopharma, Inc. IMMX declined 18.8% to close at $3.25 amid post-IPO volatility.
Bellerophon Therapeutics, Inc. BLPH dropped 18.5% to close at $2.60. Bellerophon Therapeutics jumped around 35% on Friday after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).
Vera Therapeutics, Inc. VERA dropped 18.1% to close at $20.27. Vera Therapeutics recently reported the purchase of monoclonal antibody from Pfizer.
Aemetis, Inc. AMTX declined 18.1% to settle at $12.21.
Tuya Inc. TUYA fell 17.8% to close at $5.37.
Blue Star Foods Corp. BSFC shares dropped 17.7% to settle at $2.05. Blue Star Foods recently announced plans to acquire the assets of Gault Seafood, LLC.
CNFinance Holdings Limited CNF shares declined 16.1% to close at $3.86.
Mawson Infrastructure Group, Inc. MIGI dropped 15.9% to settle at $7.26.
Rubius Therapeutics, Inc. RUBY fell 15.5% to settle at $10.63.
Sociedad Química y Minera de Chile S.A. SQM dropped 15.3% to close at $47.38.
Vicarious Surgical Inc. RBOT shares declined 15.2% to settle at $9.97.
Spruce Biosciences, Inc. SPRB fell 15.1% to close at $4.27. Spruce Biosciences shares jumped more than 102% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
Cassava Sciences, Inc. SAVA dropped 15% to settle at $36.77.
Humanigen, Inc. HGEN fell 15% to close at $3.75.
Clarus Therapeutics Holdings, Inc. CRXT fell 14.9% to close at $3.14.
Nuvalent, Inc. NUVL fell 14.5% to close at $19.54.
ForgeRock, Inc. FORG fell 14.1% to close at $21.71. The company recently disclosed two significant new features to the ForgeRock Identity Cloud called Organizations and Themed User Journeys.
Stronghold Digital Mining, Inc. SDIG fell 13.7% to close at $10.87. Stronghold Digital Mining said it acquired 9,080 bitcoin miners and secured $54 million equipment financing.
Regis Corporation RGS dropped 12.6% to settle at $2.08.
Argo Blockchain plc ARBK fell 12.3% to close at $11.38 after rising around 5% on Friday.
Ipsidy Inc. AUID fell 10.8% to close at $14.92.
Sono Group N.V. SEV declined 10.8% to close at $10.13.
Zhihu Inc. ZH shares fell 9.6% to close at $5.17. China summoned Zhihu for unlawful release of information.
California Resources Corporation CRC fell 9% to close at $38.63.
Eloxx Pharmaceuticals, Inc. ELOX shares fell 8.4% to close at $0.6764. Eloxx Pharmaceuticals shares climbed 12% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $4 price target.